Recent studies revealed that systemic inflammation was correlated with poorer prognosis in various cancers. We investigated the prognostic value of the lymphocyte-to-monocyte ratio (LMR) in patients who underwent living donor liver transplantation (LDLT) for hepatocellular carcinoma (HCC). We retrospectively analyzed the records of 216 patients who underwent LDLT for HCC. Patients were divided into high (n = 126) and low (n = 90) LMR groups. Their clinicopathological parameters and survival times were compared. To determine the mechanisms of the change in the LMR, we performed immunohistochemical analyses of CD3 and CD68 expression. (4) The Milan criteria are accepted worldwide as an indication for HCC. However, selected patients beyond the Milan criteria who receive transplants eventually achieve a good prognosis. Furthermore, new criteria were developed that contribute to decreased recurrence of HCC after LT. (5) (6) (7) (8) However, the optimal criteria for LT for HCC are still controversial.
Hepatocellular carcinoma (HCC) is the third most common cause of cancer death. (1) Although the efficacy of surgical interventions for HCC has progressed and outcomes have improved, HCC often subsequently recurs. (2) Liver transplantation (LT) is an effective treatment for HCC with liver cirrhosis. (3) Mazzaferro et al. developed the Milan criteria, which shows that patients with a single tumor <5 cm or 3 tumors <3 cm in diameter have a good prognosis after LT. (4) The Milan criteria are accepted worldwide as an indication for HCC. However, selected patients beyond the Milan criteria who receive transplants eventually achieve a good prognosis. Furthermore, new criteria were developed that contribute to decreased recurrence of HCC after LT. (5) (6) (7) (8) However, the optimal criteria for LT for HCC are still controversial.
Systemic inflammation correlates with poorer prognosis of certain cancers. (9) (10) (11) The presence of a systemic inflammatory response can be detected by the elevation of the C-reactive protein (CRP) level and the neutrophil-to-lymphocyte ratio (NLR). High serum CRP levels are associated with portal vein invasion of cancer cells, and a high preoperative serum CRP level is associated with early recurrence of HCC and poorer survival after hepatic resection. (12) Furthermore, a high NLR predicts poor survival after hepatic resection for HCC. (13) Together, the NLR and CRP levels serve as predictors of prognosis after LT for HCC. (14) (15) (16) Moreover, the lymphocyte-to-monocyte ratio (LMR) predicts poor survival of patients with certain cancers including HCC. (17) (18) (19) (20) (21) However, we are unaware of any report that demonstrates the prognostic significance of the LMR for patients who underwent LT for HCC.
This study aimed to evaluate the relationship between systemic inflammation and focal infiltration of inflammatory cells, represented by the preoperative LMR and intratumor lymphocytes and macrophages, and outcomes after patients undergo LT.
Patients and Methods

patients
We enrolled 216 consecutive patients with HCC who underwent living donor liver transplantation (LDLT) at Kyushu University Hospital, Fukuoka, Japan, between July 1999 and January 2017. All patients provided written informed consent. The ethics committee of Kyushu University approved this study.
sUrgical prOceDUre
Preoperative tumor evaluation was performed using the diagnostic imaging methods as follows: abdominal ultrasonography; thoracic and abdominal computed tomography (CT); and magnetic resonance imaging. Patients who underwent previous treatment for HCC, including transcatheter arterial chemoembolization, were evaluated >3 months after treatment. For patients with multiple tumors, the main tumors were selected by a pathologist. A description of the LDLT procedures for donors and recipients has been published previously. (6) Simultaneous splenectomy during LT was performed if recipients were positive for hepatitis C virus (HCV) or had high portal venous pressure.
iMMUnOsUppressiOn anD patient FOllOW-Up
The basic immunosuppression protocol comprised treatment with tacrolimus or cyclosporine with mycophenolate mofetil and steroids. The target trough levels for tacrolimus and cyclosporine were 10.0-14.0 and 150-250 ng/mL, respectively, for 1 month after LDLT. Mycophenolate mofetil was initially administered using 3000 mg daily, tapered to 1000 mg daily over 1 month, and tapered off at 6 months. Methylprednisolone (1000 mg) was administered after reperfusion, decreased from 200 mg to 20 mg daily over 1 week, replaced with oral prednisolone, which was tapered off at 3 months. Patients were followed monthly for the first 6 months, peripheral blood was tested for tumor markers such as alpha-fetoprotein (AFP), and ultrasonography and enhanced CT were performed every 6 months. (8) iMMUnOHistOcHeMistrY Sections of resected specimens were fixed in 10% buffered formalin, embedded in paraffin, and stained using the Envision+ system and DAB kit (DAKO, Grostrup, Denmark). Immunohistochemical staining was performed using anti-CD68 (PG-M1, DAKO) and anti-CD3 (F7.2.38, DAKO) antibodies. Serial sections were treated before incubation with primary antibodies in a microwave oven for 20 minutes, reacted with the antibodies, and then examined by 2 pathologists (Y.M. and K.Y.). The numbers of cells with cytoplasmic or membrane staining in 5 high-power fields (HPFs) were counted.
statistical analYsis
All data are expressed as the mean ± standard deviation. Independent χ 2 tests were used to compare categorical variables. Continuous variables were compared using unpaired t tests. The LMRs were compared using a paired t test. Survival curves were analyzed using the Kaplan-Meier method and compared using the log-rank test. The Cox proportional hazards model was used for multivariate analyses, and the variables were age, sex, hepatitis B surface antigen (HBsAg), HCV antibody (Ab), Child-C, Model for End-Stage Liver Disease (MELD) score, AFP, des-gamma-carboxyprothrombin (DCP), tumor size, tumor number, poor differentiation, vascular invasion, high NLR, and low LMR. The best cutoff value of the LMR was
Original article | 1605 determined using a receiver operating characteristic curve with a minimum P value approach. Adjustment for covariates and the Cox proportional hazards model was performed using JMP software (SAS Institute, Cary, NC). P values of <0.05 were considered statistically significant.
Results
patients' clinicOpatHOlOgical cHaracteristics
The median observation period was 6.2 years (range, 0.1-15.5 years). The mean age of patients with HCC upon LDLT was 58.2 years. The study included 132 (61.1%) patients who were previously treated, 86 (39.8%) patients with bilobar distribution of HCC, and 72 (33.6%) patients beyond the Milan criteria. The best cutoff value of LMR for postoperative prognosis was determined using a minimum P value approach. LMR = 2.75 was the best cutoff point for postoperative prognosis. The patients were divided into high-LMR (n = 126) and low-LMR (n = 90) groups (Table 1) . The low-LMR group was significantly associated with a high MELD score (P = 0.0003), high proportion of Child-Pugh C patients (P = 0.0099), high serum AFP (P = 0.0109), high DCP (P = 0.004), high NLR (P <0.001), increased blood loss (P = 0.01), more nodules detected using imaging (P = 0.03), larger pathological tumor size (P = 0.02), and more nodules detected using histopathology (P = 0.02).
prOgnOstic cOMparisOn BetWeen tHe HigH-anD lOW-lMr grOUps
The overall survival rates of the patients in the highand low-LMR groups are shown in Fig. 1A . The overall 1-, 3-, 5-, and 10-year survival rates were 95.2%, 90.0%, 90.0%, and 85.0% in the high-LMR group (>2.75) and 87.2%, 72.4%, 64.6%, and 58.5% in the low-LMR group (≤2.75), respectively, which were significantly different (P <0.001). The recurrence-free survival rates of the patients in the high-and low-LMR groups are shown in Fig. 1B . The recurrence-free 1-, 3-, 5-, and 10-year survival rates were 98.3%, 95.6%, 95.6%, and 92.4% in the high-LMR group and 86.3%, 75.3%, 71.3%, and 69.1% in the low-LMR group, respectively, which were significantly different (P < 0.001).
signiFicance OF tHe lMr FOr preDicting tHe prOgnOsis OF patients BeYOnD tHe Milan criteria
In our institute, the prognosis of patients beyond the Milan criteria was poorer than those of the patients within Milan criteria. The overall and recurrence-free 5-year survival rate was 89.5% and 96.5% in the patients within the Milan criteria and 63.5% and 66.1% in the patients beyond Milan criteria. To evaluate the significance of LMR for predicting the prognosis of the patients beyond the Milan criteria, we compared the prognoses of the high-and low-LMR groups of patients beyond the Milan criteria ( Table 2 ). The low-LMR group was significantly associated with younger age (P = 0.0303), high MELD score (P = 0.0259), high serum DCP (P = 0.0172), high NLR (P = 0.0060), larger tumor size determined using imaging (P = 0.0481), more nodules determined using imaging (P = 0.0304), and larger pathological tumor size (P = 0.01). The overall and recurrence-free survival rates of patients beyond the Milan criteria in the high-and low-LMR groups are shown in Fig. 2A .8% in the low-LMR group, respectively, which were significantly different (P < 0.001). Furthermore, multivariate proportional hazard models identified low LMR as an independent prognostic factor of overall survival (P = 0.003) and recurrence-free survival (P = 0.03; Table 3 ).
signiFicant cHange OF tHe lMr aFter lDlt Or UpOn recUrrence
We next evaluated the LMRs of patients with HCC who underwent LDLT. We found that in patients with or without recurrence the LMR temporarily decreased 1 month after LDLT, but the LMR increased again 1 year after LDLT (Fig. 3A,B) . There was no difference between the 2 groups. However, interestingly, low LMR at the time of recurrence was significantly associated with poor prognosis after recurrence (P = 0.040; Fig. 3C ).
iMMUnOHistOcHeMical analYsis
We performed immunohistochemical assays to detect CD3 and CD68 expression in 166 sections (Fig. 4A,B) . We compared tumor infiltration 
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between the high-LMR and low-LMR groups, which was indicated by the presence of CD3-positive cells (P < 0.001; Fig. 4C ) and CD68-positive cells (P = 0.04; Fig. 4D ). Interestingly, the ratio of CD3-positive cells to CD68-positive cells was significantly lower in the low-LMR group compared with that of the high-LMR group (P < 0.0001; Fig. 4E ). NOTE: Data are presented as n (%) or mean (range). 
Discussion
In the present study, we retrospectively analyzed 216 patients who underwent LDLT for HCC and demonstrated that a low LMR significantly correlated with a high MELD score; more patients with Child-Pugh C; elevation of AFP, DCP, and NLR; large tumor size; more tumors; and poorer prognosis. These findings indicate that the LMR was associated with poor liver function, higher expression levels of tumor markers, and a higher grade of malignancy. Low LMR in both before transplant and after recurrence of HCC was associated with poor prognosis and low LMR before transplant was identified as an independent prognostic factor, particularly among patients beyond the Milan criteria. The 5-year overall survival rate of the high-LMR group beyond the Milan criteria was 86.1%, which is comparable with the overall survival rates of patients within the Milan criteria. (4) LMR may therefore serve as a new predictive marker to improve the survival of patients with a good prognosis who are beyond the Milan criteria. The patients with high LMR might have strong immunity or their tumor might have the ability of immune suppression.
A meta-analysis of HCC found that a high LMR is associated with increased overall survival and Original article | 1609 disease-free survival after hepatic resection. (22) The present study is the first to our knowledge to evaluate the significance of LMR in patients who underwent LT for HCC. Unlike hepatic resection for HCC, a healthy donor is required, and there are few effective therapies for the recurrence of HCC after LDLT. Thus, the indication for LDLT for HCC should be strictly selected as a useful marker to predict the prognosis of patients with HCC before they undergo LDLT. The LMR, which is very simple to calculate and only requires a standard blood test, serves as a valuable marker for predicting the prognosis of patients with HCC before they undergo LDLT. The present study did not aim to identify the mechanism underlying the prognostic significance of LMR. Generally, cytokines and chemokines produced by cancer cells reflect inflammation that occurs locally and systemically during cancer progression. Tumorinfiltrating lymphocytes (TILs) may represent important antitumor effector cells associated with improved prognosis. (23) In the present study, the LMR decreased 1 month after LDLT in almost all of the patients, and the LMR increased again 1 year after LDLT. These findings indicate that immunosuppression after LDLT caused the decrease in LMR, and the reduction of immunosuppression 1 year after LDLT caused LMR to increase. In the case of high LMR, HCC induced the activation of tumor immunity through recruitment of T cells. Moreover, increased activation of tumor immunity may have contributed to the better prognosis of the high-LMR group. Interestingly, the ratio of CD3-positive to CD68-positive cells was significantly associated with LMR, indicating that the LMR of peripheral blood reflected the immune response in the HCC microenvironment.
The phenotypes of TILs are important for antitumor immunity and prognosis. For example, the balance of regulatory and cytotoxic T cells within a tumor is associated with prognosis of HCC after treatment. (24) (25) (26) A future study should evaluate the phenotypes of TILs and circulating T cells in patients with HCC who undergo LT. We predict that the phenotypic balance of TILs and circulating T cells will be similar, as indicated by our present findings.
Sasaki et al. showed that the preoperative absolute count of peripheral blood monocytes may be related to tumor progression and serves as an independent risk factor for recurrence of HCC after resection. (27) Furthermore, lymphopenia is a prognostic factor for recurrence of HCC after LT. (28) Monocytes can affect the tumor microenvironment by differentiating into tumor-associated macrophages (TAMs) that can promote carcinogenesis, recurrence, and metastasis in HCC. (29) The immunosuppressive effect of monocytes implies that monocytosis will attenuate the antitumor function of the immune system and promote the formation and development of tumors. For example, TAMs in the peripheral stroma of HCC suppress tumor immunity through programmed death ligand 1, which is consistent with the results of the present study. (29) TILs and TAMs play important roles in tumor immunity. The results of the present study indicate that peripheral blood lymphocytes and monocytes may function in a manner similar to that of TILs and TAMs, respectively. Therefore, the peripheral blood count may serve as a marker of immune status in the tumor microenvironment, and as such, represents a major discovery that will significantly improve the prognosis of patients with HCC who undergo LT.
This study has several limitations. First, this was a single-center retrospective study. Second, the mechanism of the correlation of LMR with prognosis was not identified. Multi-institutional studies with more patients and additional data are required to confirm the results of the current study. Further investigations are required to identify the mechanisms responsible for the association between LMR and tumor immunity.
In conclusion, our study shows that the preoperative LMR of the peripheral blood of patients with HCC who underwent LDLT served as an easy and useful factor for predicting prognosis and that the LMR reflected the immune status of the HCC microenvironment. These findings will contribute to the selection of patients with HCC patients with good prognoses before LT, even if they are beyond the Milan criteria. 
